Recent trade makes Dianthus Therapeutics Inc (DNTH) Stock an appealing buy
Cantor Fitzgerald raised the price target for the Dianthus Therapeutics Inc (NASDAQ:DNTH) stock to “an Overweight”. The rating was released on June 27, 2024, according to finviz. The research report from Stifel has initiated the stock to Buy, with a price target set at $44. The stock was initiated by Jefferies, who disclosed in a […]
Offering unique exposure at competitive prices: Dianthus Therapeutics Inc (DNTH) Stock
H.C. Wainwright raised the price target for the Dianthus Therapeutics Inc (NASDAQ:DNTH) stock to “a Buy”. The rating was released on May 16, 2024, according to finviz. The research report from Jefferies has initiated the stock to Buy, with a price target set at $22. The stock was initiated by Wedbush, who disclosed in a […]
There Is Nothing Like Dianthus Therapeutics Inc (DNTH) Stock
H.C. Wainwright raised the price target for the Dianthus Therapeutics Inc (NASDAQ:DNTH) stock to “a Buy”. The rating was released on May 16, 2024, according to finviz. The research report from Jefferies has initiated the stock to Buy, with a price target set at $22. The stock was initiated by Wedbush, who disclosed in a […]
It’s an all-out bull run for Dianthus Therapeutics Inc (DNTH) Stock
H.C. Wainwright raised the price target for the Dianthus Therapeutics Inc (NASDAQ:DNTH) stock to “a Buy”. The rating was released on May 16, 2024, according to finviz. The research report from Jefferies has initiated the stock to Buy, with a price target set at $22. The stock was initiated by Wedbush, who disclosed in a […]
